Scispot enjoys robust financial stability, being profitable and backed by notable venture capital sources including Y Combinator, Breakwater Ventures, Pack Ventures, Incisive Ventures, and the University of Waterloo (Velocity Fund). Additionally, we receive provincial and federal support from the Government of Ontario (Ontario Genomics) and the Federal Government of Canada (Ontario Centre of Innovation). Our financial runway extends beyond seven years, even without the infusion of new capital. In customer acquisition, we maintain a selective approach, aiming to onboard a few new customers each week to ensure their successful integration with our platform.

It’s a valid point to consider. Scispot is designed specifically to minimize your reliance on any single tool. Our platform integrates seamlessly with a range of competing ELN/LIMS, databases, and cloud services like AWS, Azure, and GCP. This means you always have the option to move your data to your own systems. Additionally, we ensure your data is backed up hourly on our AWS infrastructure. You own your data, and you can download and migrate it at any time. We are SOC 2 and HIPAA compliant.

Scispot provides full access to all your data through comprehensive APIs and built-in connectors, ensuring that you can extract, utilize, and migrate your data seamlessly, even to your own cloud storage or databases like AWS S3, Redshift, GCP, Microsoft Blob or any other ELN or LIMS. In contrast, Benchling restricts API access in basic plans and does not expose every data point in its original GUI format, making it challenging to fully extract and utilize all your information. This leads to excessive dependence on Benchling.

Scispot offers flexible, transparent pricing plans that are specifically tailored to the needs of startups and smaller, growing companies. Benchling’s pricing, designed for enterprise customers like big pharma, is often complex and costlier, posing a significant barrier for smaller organizations seeking efficient scalability.